Commentary|Events|September 15, 2026

BioPharm International

  • BioPharm International September October 2026
  • Volume 39
  • Issue 5

Architecting the Future: The Evolution of IT Landscape in the Biopharma Industry

Fact checked by: Ron Panarotti

As data volumes explode, clinical data harmonization, hybrid cloud, and AI are reshaping biopharma IT into the industry's core growth engine.

The biopharmaceutical industry is undergoing a profound transformation driven by rapid technological advancements, shifting demographics, and stringent regulatory environments. As organizations face unprecedented pressure to accelerate drug discovery, reduce costs, and improve patient outcomes, the role of information technology (IT) has shifted fundamentally.

Related to this article

The BioPharm Brief: FDA’s Fast-Track Pilot Reportedly Stalls, a Long-Acting Bispecific for Atopic Dermatitis, and a Twice-Yearly Obesity Approach
FDA has reportedly shelved its Commissioner’s National Priority Voucher pilot and paused publishing complete response letters, Zai Lab’s IL-13/IL-31Rα bispecific ZL-1503 shows a 40- to 50-day half-life that points to dosing every 12 weeks, and Wave Life Sciences reports 1-year INLIGHT data for its INHBE-silencing siRNA WVE-007 in obesity.